In 2014, can we do better than CA125 in the early detection of ovarian cancer?
Explore this paper's citation graph
Summary
Current biomarkers, imaging, and multimodality screening strategies in the context of emerging technologies are summarized to make progress in ovarian cancer screening.
- Type
- article
- Published
- 2014-08-26
- Cited by
- 76
- References
- 133
- OpenAlex
- https://openalex.org/W25225597
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:22301785
Keywords
Political science
References
- Ovarian cancer screening and early detection in the general population.
- Evaluation of the Risk of Malignancy Index in daily clinical management of adnexal masses.
- Prospective Evaluation of Serum CA 125 Levels for Early Detection of Ovarian Cancer
- Prevention and early detection of ovarian cancer: mission impossible?
- Analysis of albumin-associated peptides and proteins from ovarian cancer patients.
- Risk of malignancy index used as a diagnostic tool in a tertiary centre for patients with a pelvic mass
- The HE4 (WFDC2) protein is a biomarker for ovarian carcinoma.
- Role of common genetic variants in ovarian cancer susceptibility and outcome: progress to date from the ovarian cancer association consortium (OCAC)
- Proteomics and biomarkers for ovarian cancer diagnosis.
- Improving strategies for diagnosing ovarian cancer: a summary of the International Ovarian Tumor Analysis (IOTA) studies
- Comparison of seven immunoassays for the quantification of CA 125 antigen in serum.
- The CA 125 tumour-associated antigen: a review of the literature.
- Development of Multiplexed Bead-Based Immunoassays for the Detection of Early Stage Ovarian Cancer Using a Combination of Serum Biomarkers
- Results From Four Rounds of Ovarian Cancer Screening in a Randomized Trial
- A comparison between an ultrasound based prediction model (LR2) and the risk of ovarian malignancy algorithm (ROMA) to assess the risk of malignancy in women with an adnexal mass.
- Screening for ovarian cancer in the general population.
- Pathology and classification of ovarian tumors
- Molecular Pathogenesis and Extraovarian Origin of Epithelial Ovarian Cancer. Shifting the Paradigm
- Ovarian malignancy risk stratification of the adnexal mass using a multivariate index assay.
- Tissue Distribution of a Coelomic- Epithelium‐Related Antigen Recognized by the Monoclonal Antibody OC125
Cited by
- Does the Risk of Ovarian Malignancy Algorithm Provide Better Diagnostic Performance Than HE4 and CA125 in the Presurgical Differentiation of Adnexal Tumors in Polish Women?
- Identification of Epithelial Ovarian Tumor-Specific Aptamers
- Upregulation of miR-572 transcriptionally suppresses SOCS1 and p21 and contributes to human ovarian cancer progression
- Highly effective antiangiogenesis via magnetic mesoporous silica-based siRNA vehicle targeting the VEGF gene for orthotopic ovarian cancer therapy
- Urinary microRNA-30a-5p is a potential biomarker for ovarian serous adenocarcinoma.
- Inhibition of IL-6/STAT3 axis and targeting Axl and Tyro3 receptor tyrosine kinases by apigenin circumvent taxol resistance in ovarian cancer cells.
- Gallic acid, a phenolic compound, exerts anti-angiogenic effects via the PTEN/AKT/HIF-1α/VEGF signaling pathway in ovarian cancer cells
- Current state of biomarkers in ovarian cancer prognosis.
- Diagnostic performance of contrast-enhanced ultrasound for ovarian cancer: a meta-analysis.
- Proteomics of ovarian cancer: functional insights and clinical applications
- In vitro selection of RNA aptamers against CA125 tumor marker in ovarian cancer and its study by optical biosensing.
- Overexpression of centromere protein K (CENPK) in ovarian cancer is correlated with poor patient survival and associated with predictive and prognostic relevance
- EphA8 is a prognostic marker for epithelial ovarian cancer
- Is CA-125 the Leading Biomarker in Determining Early-Onset Ovarian Cancer Diagnosis in 2016?
- Correlation analysis of urine metabolites and clinical staging in patients with ovarian cancer.
- Comparison of mesothelin and fibulin-3 in pleural fluid and serum as markers in malignant mesothelioma
- Level of HE4 is Correlated with Diagnosis of Struma Ovarii: A Case Report
- APE1 overexpression promotes the progression of ovarian cancer and serves as a potential therapeutic target
- Desenvolvimento de anticorpos anti-peptídeos sintéticos derivados da proteína transportadora de fosfato dependente de sódio NaPi2b.
- Comparison of plasma amino acid profile-based index and CA125 in the diagnosis of epithelial ovarian cancers and borderline malignant tumors
Related papers
No related papers recorded.